Get started
Author

Susanne Bremer‐Hoffmann

Observed names: BREMER-HOFFMANN Susanne, Bremer Susanne, Bremer-Hoffmann, Susanne, S. Bremer-Hoffman, S. Bremer-Hoffmann, Susanne Bremer-Hoffmann
ORCID: 0000-0001-9014-6131
Observed ORCID: 0000-0001-9014-6131
OpenAlex ID: A5083340646
Mapping of the available standards against the regulatory needs for nanomedicines
2018 · Blanka Halamoda‐Kenzaoui, Uwe Holzwarth, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 154
PDF
Are Existing Standard Methods Suitable for the Evaluation of Nanomedicines: Some Case Studies
2018 · Sabrina Gioria, Fanny Caputo, et al. · Nanomedicine · 137
PDF
Nanomedicines - Tiny particles and big challenges
2019 · Margareth R.C. Marques, Qiuyi Choo, et al. · Advanced Drug Delivery Reviews · 112
Main trends of immune effects triggered by nanomedicines in preclinical studies
2018 · Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann · International Journal of Nanomedicine · 105
Identification of regulatory needs for nanomedicines
2018 · Susanne Bremer‐Hoffmann, Blanka Halamoda‐Kenzaoui, et al. · Journal of Interdisciplinary Nanomedicine · 105
PDF
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation
2021 · B. Halamoda-Kenzaoui, R.J. Vandebriel, et al. · Journal of Controlled Release · 93
Standardization of pluripotent stem cell cultures for toxicity testing
2012 · Francesca Pistollato, Susanne Bremer-Hoffmann, et al. · Expert Opinion on Drug Metabolism & Toxicology · 64
Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells
2016 · Dimitra Zagoura, David Canovas-Jorda, et al. · Neurochemistry International · 62
Alternative methods for regulatory toxicology – a state-of-the-art review
2014 · Worth Andrew, Viegas Barroso Joao Filipe, et al. · Joint Research Centre (European Commission) · 60
Bridging communities in the field of nanomedicine
2019 · Blanka Halamoda-Kenzaoui, Simon Baconnier, et al. · Regulatory Toxicology and Pharmacology · 55
PDF
Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition
2014 · Francesca Pistollato, Jochem Louisse, et al. · Toxicology and Applied Pharmacology · 51
PDF
Review of New Approach Methodologies for Application in Risk Assessment of Nanoparticles in the Food and Feed Sector: Status and Challenges
2024 · Shirin M. Usmani, Susanne Bremer‐Hoffmann, et al. · EFSA Supporting Publications · 47
PDF
Future perspectives for advancing regulatory science of nanotechnology-enabled health products
2022 · Blanka Halamoda-Kenzaoui, Robert Geertsma, et al. · Drug Delivery and Translational Research · 47
PDF
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
2015 · Francesca Pistollato, Susanne Bremer-Hoffmann, et al. · Targeted Oncology · 44
Tiered testing of micro- and nanoplastics using intestinal in vitro models to support hazard assessments
2021 · Gerrit Bredeck, Blanka Halamoda-Kenzaoui, et al. · Environment International · 41
PDF
Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
2020 · Blanka Halamoda-Kenzaoui, Helen Box, et al. · Precision Nanomedicine · 22
PDF
Anticipation of regulatory needs for nanotechnology-enabled health products
2019 · Halamoda Kenzaoui Blanka, Helen Box, et al. · DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)) · 21
PDF
EFSA Project on the use of New Approach Methodologies (NAMs) for the hazard assessment of nanofibres. Lot 1, nanocellulose oral exposure: gastrointestinal digestion, nanofibres uptake and local effects
2023 · Olimpia Vincentini, Anne‐Louise Blier, et al. · EFSA Supporting Publications · 20
PDF
Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?
2021 · Blanka Halamoda‐Kenzaoui, Etienne Rolland, et al. · Journal of Applied Toxicology · 20
Proposal for a qualification system for New Approach Methodologies (NAMs) in the food and feed sector: example of implementation for nanomaterial risk assessment
2024 · Andrea Haase, João Barroso, et al. · EFSA Supporting Publications · 19
PDF
MicroRNA Profiling as a Tool for Pathway Analysis in a Human In Vitro Model for Neural Development
2012 · S. Nerini-Molteni, M. Mennecozzi, et al. · Current Medicinal Chemistry · 16
Fostering scientific integrity and research ethics in a science-for-policy research organisation
2024 · Göran Lövestam, Susanne Bremer-Hoffmann, et al. · Research Ethics · 15
Changes in miRNA Expression Profiling during Neuronal Differentiation and Methyl Mercury-Induced Toxicity in Human in Vitro Models
2014 · Giorgia Pallocca, Marco Fabbri, et al. · Toxics · 11
PDF
Nanomedicines in the European translational process
2015 · Susanne Bremer-Hoffmann, Valeria Amenta, et al. · European Journal of Nanomedicine · 10
A Tanscriptomics Study to Elucidate the Toxicological Mechanism of Methylmercury Chloride in a Human Stem Cell Based In Vitro Test
2012 · K. Vojnits, R. Ensenat-Waser, et al. · Current Medicinal Chemistry · 10
Works count: 47
Citation count: 1,365
H-index: 19
I10-index: 25
Year
Topic
Type